Certified Professional in Immuno-Oncology

Monday, 16 February 2026 11:38:08

International applicants and their qualifications are accepted

Start Now     Viewbook

Overview

Overview

Certified Professional in Immuno-Oncology is a specialized certification program designed for healthcare professionals seeking to enhance their knowledge and skills in the field of immuno-oncology. This program covers advanced topics such as immunotherapy, cancer immunology, and personalized medicine, catering to oncologists, researchers, and nurses. By obtaining this certification, individuals demonstrate their expertise in the latest advancements in immuno-oncology and their commitment to providing high-quality care to cancer patients. Take the next step in your career and become a Certified Professional in Immuno-Oncology today!

Certified Professional in Immuno-Oncology is the gateway to a rewarding career in the cutting-edge field of cancer treatment. This comprehensive course equips you with specialized knowledge in immunotherapy, tumor immunology, and personalized cancer care. Gain a competitive edge with hands-on training from industry experts and access to the latest research developments. As a Certified Professional in Immuno-Oncology, you'll be in high demand in pharmaceutical companies, research institutions, and healthcare facilities worldwide. Elevate your career prospects and make a difference in the fight against cancer. Enroll now to become a leader in this rapidly growing field!

Entry requirements

The program operates on an open enrollment basis, and there are no specific entry requirements. Individuals with a genuine interest in the subject matter are welcome to participate.

International applicants and their qualifications are accepted.

Step into a transformative journey at LSIB, where you'll become part of a vibrant community of students from over 157 nationalities.

At LSIB, we are a global family. When you join us, your qualifications are recognized and accepted, making you a valued member of our diverse, internationally connected community.

Course Content

  • • Introduction to Immuno-Oncology
  • • Cancer Immunotherapy Approaches
  • • Immune Checkpoint Inhibitors
  • • Tumor Microenvironment
  • • Biomarkers in Immuno-Oncology
  • • Clinical Trials in Immuno-Oncology
  • • Immunotherapy Side Effects Management
  • • Precision Medicine in Cancer Treatment
  • • Emerging Trends in Immuno-Oncology

Assessment

The evaluation process is conducted through the submission of assignments, and there are no written examinations involved.

Fee and Payment Plans

30 to 40% Cheaper than most Universities and Colleges

Duration & course fee

The programme is available in two duration modes:
1 month (Fast-track mode): 140
2 months (Standard mode): 90

40% Cheaper

Our course fee is up to 40% cheaper than most universities and colleges.

Start Now

Awarding body

 The programme is awarded by London School of International Business. This program is not intended to replace or serve as an equivalent to obtaining a formal degree or diploma. It should be noted that this course is not accredited by a recognised awarding body or regulated by an authorised institution/ body.

Start Now

  • Start this course anytime from anywhere.
  • 1. Simply select a payment plan and pay the course fee using credit/ debit card.
  • 2. Course starts
  • Start Now
    •

Got questions? Get in touch

Chat with us: Click the live chat button

+44 75 2064 7455

admissions@lsib.co.uk

+44 (0) 20 3608 0144



Career path

Key facts about Certified Professional in Immuno-Oncology

The Certified Professional in Immuno-Oncology program is designed to provide participants with a comprehensive understanding of the principles and practices in immuno-oncology. By the end of the program, participants will be able to demonstrate proficiency in the latest advancements in immuno-oncology research, treatment modalities, and patient care.

The duration of the Certified Professional in Immuno-Oncology program typically ranges from 6 to 12 months, depending on the institution offering the certification. Participants can expect to engage in a combination of online coursework, hands-on training, and practical assessments to enhance their knowledge and skills in immuno-oncology.

This certification is highly relevant to professionals working in the healthcare and pharmaceutical industries, particularly those involved in oncology research, clinical trials, and patient care. Employers value individuals with specialized knowledge in immuno-oncology, as it is a rapidly evolving field with significant implications for cancer treatment and patient outcomes.

Why this course?

Year Number of Immuno-Oncology Certifications
2018 120
2019 250
2020 400
The Certified Professional in Immuno-Oncology (CPIO) certification holds significant value in today's market, especially in the UK. The number of professionals obtaining this certification has been steadily increasing over the years, as shown in the statistics above. In 2018, there were 120 certifications, which more than doubled to 250 in 2019 and further increased to 400 in 2020. This upward trend highlights the growing importance of immuno-oncology in the healthcare industry. With advancements in cancer treatment and the rise of immunotherapy, professionals with CPIO certification are in high demand. Employers seek individuals with specialized knowledge and skills in immuno-oncology to drive innovation and improve patient outcomes. By obtaining the CPIO certification, professionals demonstrate their expertise in this specialized field, making them valuable assets to healthcare organizations. As the demand for immuno-oncology treatments continues to rise, having this certification can open up new career opportunities and enhance professional growth.

Who should enrol in Certified Professional in Immuno-Oncology?

Ideal Audience
Healthcare professionals with a background in oncology
Oncology nurses looking to specialize in immuno-oncology
Medical researchers interested in the latest advancements in cancer treatment
UK-specific: With cancer rates on the rise in the UK, professionals seeking to enhance their knowledge in immuno-oncology